Mechanisms of psilocybin on the treatment of posttraumatic stress disorder
Journal of Psychopharmacology – October 03, 2024
Source: OpenAlex
Summary
For millions battling Posttraumatic stress, conventional treatments like pharmacotherapy or psychotherapist-led exposure therapy often prove inadequate. This debilitating condition, marked by altered mood, cognition, and heightened arousal, leaves many without relief. However, insights from clinical psychology and psychiatry are exploring psilocybin, a potent hallucinogen, as a novel approach. This psychedelic compound's mechanism of action, examined against Posttraumatic stress neurobiology, suggests it could offer a crucial new avenue in drug studies, potentially alleviating anxiety and improving patient outcomes where current options fail.
Abstract
Posttraumatic stress disorder (PTSD) is a condition that can develop after a traumatic event, causing distressing symptoms, including intrusive re-experiencing symptoms, alterations in mood and cognition, and changes in arousal and reactivity. Few treatment options exist for patients who find conventional psychotherapy and pharmacotherapy to be inaccessible, ineffective, or intolerable. We explore psilocybin as a potential treatment option for PTSD by examining the neurobiology of PTSD as well as psilocybin’s mechanism of action. Based on both pharmacodynamic and psychoanalytic principles, psilocybin may be an underexplored treatment option for patients with PTSD, though further research is required.